---
category: listing
circular_id: 78ee3202e9c2f1d8
date: '2025-08-29'
description: BSE permits trading of 1000 bonus equity shares of Ipca Laboratories
  Ltd kept in abeyance, effective September 1, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={ED9CEDD3-5E0D-4F93-B463-BE5E9EB1A3DB}&noticeno=20250829-3&dt=08/29/2025&icount=3&totcount=7&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Small bonus share listing with minimal market impact
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250829-3&attachedId=
processing:
  attempts: 1
  content_hash: ae313c5eda1545ee
  processed_at: '2025-08-29T09:22:24.379603'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-29T06:03:02+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={ED9CEDD3-5E0D-4F93-B463-BE5E9EB1A3DB}&noticeno=20250829-3&dt=08/29/2025&icount=3&totcount=7&flag=0
severity: low
source: bse
stocks:
- IPCA
tags:
- bonus-shares
- listing
- equity-shares
- ipca-laboratories
- abeyance
title: Listing of 1000 Bonus Equity Shares kept in abeyance of Ipca Laboratories Ltd
---

## Summary

BSE has announced the listing and trading permission for 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were previously kept in abeyance. These shares will be available for trading from September 1, 2025.

## Key Points

- 1000 bonus equity shares of Rs. 1/- each are being listed
- Shares were previously kept in abeyance
- ISIN: INE571A01038
- Distinctive numbers: 1171453 to 1172452
- Trading commences September 1, 2025

## Regulatory Changes

No regulatory changes - this is a standard listing notification for previously issued but held shares.

## Compliance Requirements

Trading members are informed and can facilitate trading of these securities from the effective date.

## Important Dates

- **Effective Trading Date**: September 1, 2025 (Monday)
- **Notice Date**: August 29, 2025

## Impact Assessment

Minimal market impact expected due to the small number of shares (1000) relative to the company's total equity base. This is a routine administrative listing of bonus shares that were previously held in abeyance.